Skip to main content

Month: March 2022

Press release: Late-breaking Phase 3 data at AAD 2022 show Dupixent® (dupilumab) significantly improved signs and symptoms of prurigo nodularis

Late-breaking Phase 3 data at AAD 2022 show Dupixent® (dupilumab) significantly improved signs and symptoms of prurigo nodularisDupixent significantly reduced itch at 12 weeks, and at 24 weeks nearly three times as many Dupixent patients experienced clinically meaningful reductions in itch and skin lesions There are currently no approved systemic treatments for prurigo nodularis; regulatory filings for prurigo nodularis planned in the first half of 2022Paris and Tarrytown, N.Y. March 26, 2022. Detailed positive results from the Phase 3 PRIME2 trial evaluating the safety and efficacy of Dupixent® (dupilumab) was presented today in a late-breaking session at the American Academy of Dermatology (AAD) 2022 Annual Meeting. The companies previously announced topline results from PRIME2 and a second trial called PRIME investigating the use...

Continue reading

Islandsbanki hf.: Major Shareholder Announcement – The Capital Group Companies, Inc.

Enclosed is a major shareholder announcment from The Capital Croup Companies, Inc.  Contacts Investor Relations – Margrét Lilja Hrafnkelsdóttir, ir@islandsbanki.is and tel: +354 844 4033 Public Relations – Edda Hermannsdóttir, pr@islandsbanki.is and tel: +354 844 4005 Íslandsbanki press releases If you wish to receive Íslandsbanki press releases by e-mail please register at: https://www.islandsbanki.is/en/article/email_list_ir About Íslandsbanki With a history that dates from 1875, Íslandsbanki is an Icelandic universal bank with a strong customer focus. The Bank believes in moving Iceland forward by empowering its customers to succeed – reflecting a commitment to run a solid business that is a force for good in society. Driven by the ambition to be #1 for service, Íslandsbanki’s banking model is led by three business divisions...

Continue reading

AnPac Bio-Medical Sciences Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request Hearing

PHILADELPHIA, March 26, 2022 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, announced that on March 24, 2022, it received a Staff determination letter (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company of the Staff’s determination to delist the Company’s securities from The Nasdaq Global Market due to its failure to regain compliance with the minimum $50,000,000 Market Value of Listed Securities required for continued listing as set forth in Listing Rule 5450(b)(2)(A) (the “ MVLS”), following the 180 calendar day compliance period. The Letter also indicates that the Company has not met the...

Continue reading

Magna Posts 2021 Annual Report

AURORA, Ontario, March 25, 2022 (GLOBE NEWSWIRE) — Magna International Inc. (TSX: MG; NYSE: MGA) today announced that its 2021 Annual Report, including Management’s Discussion and Analysis and Audited Consolidated Financial Statements, Annual Information Form (AIF) and Form 40-F, are now available on the company’s website, www.magna.com.  Magna has also filed these documents with the Canadian Securities Administrators (accessible through its website at www.sedar.com) and the U.S. Securities and Exchange Commission (accessible through its website at www.sec.gov/edgar). Our 2022 Annual and Special Meeting of Shareholders will be held on Tuesday May 3, 2022, commencing at 10:00 a.m. (Eastern Daylight Time). The meeting is being conducted as a virtual-only meeting accessible at www.virtualshareholdermeeting.com/mga2022.         Magna...

Continue reading

CapStar Ranked Among Nation’s Highest Performing Banks

NASHVILLE, Tenn., March 25, 2022 (GLOBE NEWSWIRE) — CapStar Financial Holdings, Inc. (“CapStar”, the “Company”) (NASDAQ: CSTR), the parent company of CapStar Bank, was recently recognized by two leading industry observers as one of the nation’s highest-performing banks. Launched more than a decade ago to assess the performance of community banks and credit unions, S&P Global Market Intelligence ranked CapStar #18 among banks nationwide with assets between $3 billion and $10 billion for 2021 based on returns, growth, and efficiency, with a premium placed on the strength and risk profile of balance sheets. CapStar was the second highest ranked Southeast institution and Tennessee’s highest-ranking institution. Hovde Group, a boutique investment bank focused exclusively on the financial services sector, included CapStar among...

Continue reading

GobiMin Inc. Announces Change of Directors

Montreal, Canada, March 25, 2022 (GLOBE NEWSWIRE) — (TSXV: GMN) GobiMin Inc. (the “Company” or “GobiMin”) announces that Mr. Hubert Marleau has tendered his resignation as Director of the Company effective on March 25, 2022. Concurrent with Mr. Hubert Marleau’s resignation, the Company is pleased to announce that Mr. Philippe Marleau has been appointed as Director of the Company with effect from March 25, 2022. Mr. Philippe Marleau is the son of Mr. Hubert Marleau. He is currently the chief executive officer of Palos Capital Corporation (“Palos”), a boutique financial services firm focused on wealth management and merchant banking activities. Previously, Philippe was the chief executive officer of IOU Financial Inc. (“IOU”), a tech-enabled lender to small businesses that is listed on the TSX Venture Exchange. He currently serves...

Continue reading

Jasper Therapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., March 25, 2022 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a biotechnology company focused on hematopoietic cell transplant therapies, today announced that, on March 21, 2022, it granted an option to purchase 1,704,328 shares of Jasper’s voting common stock (the “Option”) to Ronald Martell, Jasper’s newly appointed President and Chief Executive Officer. This inducement award was granted pursuant to the Jasper 2022 Inducement Equity Incentive Plan, approved by the compensation committee of Jasper’s board of directors on March 14, 2022, and granted as an inducement material to Mr. Martell’s employment with Jasper in accordance with Nasdaq Listing Rule 5635(c)(4). The Option has an exercise price of $3.54 per share and will vest over four years, with 25% of the total number of shares...

Continue reading

TAAT® Obtains Registered Trademark Status in Eight Global Markets

The brand name “TAAT®” is now a registered trademark in the United States, the European Union, Australia, New Zealand, the Philippines, Israel, India, and MexicoPicture 1 First launched in the United States in December of 2020, TAAT® has become well-known as an alternative to tobacco cigarettes containing no nicotine or tobacco in its base material. In 2021, the Company filed trademark applications in several global jurisdictions and as of this writing has secured registered trademarks in the United States, as well as seven other global markets to include the European Union.LAS VEGAS and VANCOUVER, British Columbia, March 25, 2022 (GLOBE NEWSWIRE) — TAAT® GLOBAL ALTERNATIVES INC. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) (the “Company” or “TAAT®”) is pleased to announce that its trademark applications on the TAAT® brand name...

Continue reading

Oak Valley Community Bank Announces Vice President Promotion

OAKDALE, Calif., March 25, 2022 (GLOBE NEWSWIRE) — Oak Valley Community Bank, a wholly-owned subsidiary of Oak Valley Bancorp (NASDAQ: OVLY), announced the promotion of Lisa Melville to Vice President, Commercial Loan Officer. Melville is based out of the bank’s Downtown Sonora Branch. Melville has been in banking for over 40 years, nearly 20 of which have been in commercial banking. When Oak Valley acquired Mother Lode Bank in 2015, Melville was a great fit with the commercial team. She has played an integral role in representing both Sonora branches and serving clients throughout Tuolumne County, as well as the Eastern Sierra. In addition, Melville has been instrumental in our efforts to assist businesses in the Mother Lode region with PPP loan and forgiveness applications. Melville will continue to focus on commercial lending...

Continue reading

Patriot One Technologies to Host Live Corporate Webinar on March 31st at 2pm ET and Closes Public Offering

Announcement Patriot One Technologies to Host Live Corporate Webinar on March 31st at 2pm ET and Closes Public OfferingTHIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATESPeter Evans, CEO & Director, will provide a corporate update via a live presentation followed by live Q&A Investors and other interested parties invited to join and learn more about Patriot One’s recent corporate developments and outlook Patriot One discloses additional information in connection with it’s Public OfferingTORONTO, March 25, 2022 (GLOBE NEWSWIRE) — Patriot One Technologies (TSX: PAT) (OTCQX: PTOTF) (FRANKFURT: 0PL) (“Patriot One” or the “Company”) is pleased to announce that the Company’s CEO & Director, Peter...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.